Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis

Nonalcoholic steatohepatitis (NASH) is the most severe and progressive form of nonalcoholic fatty liver disease (NAFLD), which can lead to life-threatening conditions, however, there is still no approved drug for the treatment of NASH. In this study we used human-like NASH mouse model and treated or...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganbold, Munkhzul, Owada, Yohei, Ozawa, Yusuke, Shimamoto, Yasuhiro, Ferdousi, Farhana, Tominaga, Kenichi, Zheng, Yun-Wen, Ohkohchi, Nobuhiro, Isoda, Hiroko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838085/
https://www.ncbi.nlm.nih.gov/pubmed/31700054
http://dx.doi.org/10.1038/s41598-019-52736-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838085/
https://www.ncbi.nlm.nih.gov/pubmed/31700054
http://dx.doi.org/10.1038/s41598-019-52736-y

Ejemplares similares